Determination of polyamine metabolome in plasma and urine by ultrahigh performance liquid chromatography-tandem mass spectrometry method: Application to identify potential markers for human hepatic cancer

Analytica Chimica Acta

Volumn 791, Issue , 2013, Pages 36-45

  Liu, Ran ^a   Li, Qing ^a   Ma, Ran ^a   Lin, Xiaohui ^a   Xu, Huarong ^a   Bi, Kaishun ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cancer biomarker; Hepatic cancer; Plasma and urine; Polyamine metabolome; UHPLC MS MS

Indexed keywords

CANCER BIOMARKERS; HEPATIC CANCER; LIMITS OF QUANTITATIONS; METABOLOMES; S ADENOSYL L METHIONINES; SIMULTANEOUS DETERMINATIONS; U-HPLC-MS; ULTRAHIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRIES;

AMINES; AMINO ACIDS; BODY FLUIDS; DISEASES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORGANIC POLYMERS; POSITIVE IONS;

PLASMAS;

1,3 PROPANEDIAMINE; 4 AMINOBUTYRIC ACID; AGMATINE; ARGININE; CADAVERINE; LYSINE; N ACETYLPUTRESCINE; N ACETYLSPERMIDINE; N ACETYLSPERMINE; ORNITHINE; POLYAMINE; PUTRESCINE; S ADENOSYLMETHIONINE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; LIVER CANCER; MALE; METABOLOMICS; MOUSE; NONHUMAN; POLYAMINE METABOLISM; PRECIPITATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

CANCER BIOMARKER; HEPATIC CANCER; HEPTAFLUOROBUTYRIC ACID; HFBA; INTERNAL STANDARD; IS; MRM; MULTIPLE REACTION-MONITORING; PLASMA AND URINE; POLYAMINE METABOLOME; UHPLC-MS/MS; ULTRAHIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIVER NEOPLASMS; METABOLOME; POLYAMINES; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84880962868     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2013.06.044     Document Type: Article

References (28)

1. Jänne J., Alhonen L., Keinänen T.A., Pietilä M., Uimari A., Pirinen E., Hyvönen M.T., Järvinen A. J. Cell. Mol. Med. 2005, 9:865-882.
2. Pegg A.E., McCann P.P. Am. J. Physiol. 1982, 243:212-221.
3. Wallace H.M. Biochem. Soc. Trans. 2003, 31:354-355.
4. Russell D.H., Levy C.C., Schimpff S.C., Hawk I.A. Cancer Res. 1971, 31:1555-1558.
5. Russell D.H. Clin. Chem. 1977, 23:22-27.
6. Russell D.H., Gullino P.M., Marton L.J., LeGendre S.M. Cancer Res. 1974, 34:2378-2381.
7. Russell D.H., Durie B.G., Salmon S.E. Lancet 1975, 25:797-799.
8. Moinard C., Cynober L., de Bandt J.P. Clin. Nutr. 2005, 24:184-197.
9. Horn Y., Beal S.L., Walach N., Lubich W.P., Spigel L., Marton L.J. Cancer Res. 1982, 42:3248-3251.
10. Casero R.A., Marton L.J. Nat. Rev. Drug Discov. 2007, 6:373-390.
11. Wallace H.M., Fraser A.V., Hughes A. Biochem. J. 2003, 376:1-14.
12. Seiler N., Delcros J.G., Moulinoux J.P. Int. J. Biochem. Cell Biol. 1996, 28:843-861.
13. Li L., Hara K., Liu J., Yu Y., Gao L., Wang Y., Wang Y. J. Chromatogr. B 2008, 876:257-260.
14. Ekegren T., Gomes-Trolin C. Anal. Biochem. 2005, 338:179-185.
15. Gaboriau F., Havouis R., Moulinoux J.P., Delcros J.G. Anal. Biochem. 2003, 318:212-220.
16. Choi M.H., Kim K.R., Chung B.C. J. Chromatogr. A 2000, 897:295-305.
17. Hawel L., Byus C.V. Anal. Biochem. 2002, 311:127-132.
18. Patel M., Shariff M.I., Ladep N.G., Thillainayagam A.V., Thomas H.C., Khan S.A., Taylor-Robinson S.D. J. Eval. Clin. Pract. 2012, 18:335-342.
19. Gosetti F., Mazzucco E., Gennaro M.C., Marengo E. Anal. Bioanal. Chem. 2013, 405:907-916.
20. Kubo A., Ohmura M., Wakui M., Harada T., Kajihara S., Ogawa K., Suemizu H., Nakamura M., Setou M., Suematsu M. Anal. Bioanal. Chem. 2011, 400:1895-1904.
21. Liu R., Jia Y., Cheng W., Ling J., Liu L., Bi K., Li Q. Talanta 2011, 83:751-756.
22. Liu R., Bi K., Jia Y., Wang Q., Yin R., Li Q. J. Mass Spectrom. 2012, 47:1341-1346.
23. Wang Q., Wang Y., Liu R., Yan X., Li Y., Fu H., Bi K., Li Q. Biomed. Chromatogr. 2013, 27:208-215.
24. Stevens A.P., Dettmer K., Kirovski G., Samejima K., Hellerbrand C., Bosserhoff A.K., Oefner P.J. J. Chromatogr. A 2010, 1217:3282-3288.
25. Guidance for Industry Bioanalytical Method Validation (updated) 2001, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
26. Guideline on bioanalytical method validation. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
27. Peng X.Q., Wang F., Geng X., Zhang W.M. Exp. Rev. Proteomics 2009, 6:551-561.
28. Patel N.R., McPhail M.J., Shariff M.I., Keun H.C., Taylor-Robinson S.D. Exp. Rev. Gastroenterol. Hepatol. 2012, 6:239-251.